Tenax Therapeutics Provides Regulatory Update on Levosimendan

Go back to Tenax Therapeutics Provides Regulatory Update on Levosimendan
(NASDAQ: TENX) Delayed: 1.97 -0.16 (7.51%)
Previous Close $2.13    52 Week High $3.40 
Open $2.13    52 Week Low $1.34 
Day High $2.14    P/E N/A 
Day Low $1.95    EPS $0.00 
Volume 3,740,756